MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

OHR Pharmaceutical Company Profile (NASDAQ:OHRP)

Consensus Ratings for OHR Pharmaceutical (NASDAQ:OHRP) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $21.50 (687.55% upside)

Analysts' Ratings History for OHR Pharmaceutical (NASDAQ:OHRP)
Show:
DateFirmActionRatingPrice TargetActions
6/16/2016Roth CapitalReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Chardan CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Brean CapitalReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Cowen and CompanyInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for OHR Pharmaceutical (NASDAQ:OHRP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q2($0.18)($0.17)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2015Q415($0.20)($0.13)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q215($0.17)($0.12)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2015Q115($0.20)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/22/2014($0.10)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for OHR Pharmaceutical (NASDAQ:OHRP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.23)($0.23)($0.23)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)
Dividend History for OHR Pharmaceutical (NASDAQ:OHRP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for OHR Pharmaceutical (NASDAQ:OHRP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/20/2016Jason Scott SlakterCEOBuy8,786$2.85$25,040.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Samuel BackenrothCFOBuy2,468$2.84$7,009.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Jason Scott SlakterCEOBuy3,682$3.11$11,451.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Jason Scott SlakterCEOBuy28,068$3.15$88,414.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Samuel BackenrothCFOBuy2,500$3.17$7,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2016Jason Scott SlakterCEOBuy6,250$3.35$20,937.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Jason Scott SlakterCEOBuy6,250$3.63$22,687.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Jason Scott SlakterCEOBuy6,250$3.11$19,437.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Jason Scott SlakterCEOBuy6,250$3.62$22,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Jason Scott SlakterCEOBuy3,000$4.07$12,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Jason Scott SlakterCEOBuy13,350$3.00$40,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Irach B TaraporewalaCEOBuy3,705$6.75$25,008.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015June Sherie AlmenoffDirectorBuy6,000$6.75$40,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Samuel BackenrothCFOBuy1,500$6.75$10,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014June Sherie AlmenoffDirectorBuy2,200$8.08$17,776.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2014Ira A GreensteinDirectorBuy1,000$8.40$8,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2014June Sherie AlmenoffDirectorBuy3,200$8.34$26,688.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Thomas M RiedhammerDirectorBuy6,900$7.39$50,991.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Ira A GreensteinDirectorBuy2,500$10.20$25,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014June Sherie AlmenoffDirectorBuy5,500$10.25$56,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for OHR Pharmaceutical (NASDAQ:OHRP)
DateHeadline
06/29/16 05:31 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Company Rating and Target Watch - Telanagana Press
06/29/16 05:31 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Stock Performance and Session Recap - Engelwood Daily
06/29/16 05:31 PMOhr Pharmaceuticals Inc. (OHRP) Jumps 6.18% on June 28 - Equities.com
06/28/16 05:34 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Reviewing Stock Performance - Press Telegraph
06/28/16 05:34 PMStock Performance in Review: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 05:35 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Recent Performance and Company Stock Review - Engelwood Daily
06/27/16 05:35 PMShare Update and Earnings Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 05:35 PMActive Company Share Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 09:48 AMWatching Stock Sentiment for:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/26/16 04:48 PMStock Sentiment Review for :Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/26/16 04:48 PMActive Stock Performance : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
06/25/16 05:08 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Update on Stock Performance - Press Telegraph
06/24/16 05:35 PMCovering the Bases on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Where is the Stock Going? - Press Telegraph
06/24/16 05:35 PMConsensus View on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Stock and Check on Movement - Press Telegraph
06/24/16 05:35 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Current Performance Check and Stock Direction Review - Engelwood Daily
06/24/16 05:35 PMImpact Score Outlook on:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/24/16 08:13 AMNew Broker Ratings For Ohr Pharmaceuticals, Inc. (OHRP) - FTSE News
06/24/16 08:13 AMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Earnings Glance and Target Price Review - Engelwood Daily
06/20/16 07:14 AMThis Weeks Broker Views For Ohr Pharmaceuticals, Inc. (OHRP) - Fiscal Standard
06/08/16 05:06 PMOhr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q2, 2016 By the Numbers : June 8, 2016 -
06/06/16 09:19 AMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Check on Sentiment Score - HNN
06/04/16 05:38 PMTarget Price Review Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN
06/03/16 06:06 PMSentiment Score Update: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN
06/03/16 08:30 AMShare Rating Focus on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN - Share Rating Focus on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.67 on shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus ...and more »
06/02/16 05:59 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Rundown on Share Performance - HNN - Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Rundown on Share PerformanceHNNIn the latest trading period, Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) shares have seen a change of -0.31%. During the period, the stock has moved up to a high of $3.25 and dipped to a low of $3.13. Looking at a broader view of stock performance, shares ...and more »
06/02/16 05:59 PMStock Action Update: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - HNN - Stock Action Update: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)HNNShares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) are trading -47.39% year-to-date. Over the previous month, shares have changed -2.71%. A broader check sees the company's quarterly performance at -12.70%. For the past year, share performance sits ...and more »
06/02/16 05:59 PMTarget Price Outlook on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN - Target Price Outlook on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)HNNEquity analysts that track Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) shares have provided targets on where they believe the stock will move in the future. The present consensus target price compiled using analysts polled by Zacks Research sits at $16.and more »
06/02/16 05:59 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Near Term Target Update - Stock Tick Tock - Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Near Term Target UpdateStock Tick TockSell-siders covering shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) have a consensus price target of $16 for the next 12-18 months. Analysts study the companies they cover in order to present the sell-side institutions with the information needed to ...and more »
06/02/16 05:59 PMBroker Watchlist: Ohr Pharmaceuticals, Inc. (OHRP) - Share Trading News - Broker Watchlist: Ohr Pharmaceuticals, Inc. (OHRP)Share Trading News03/27/2015 – Ohr Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 15 price target on the stock. The share price of Ohr Pharmaceuticals, Inc. (OHRP) was up +0.00% during the last trading session ...Ohr Pharmaceuticals, Inc. (OHRP) Analyst ReviewRisers & FallersInsiders Are Gradually Buying Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)HNNOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Price Target ProjectionsNews Tribuneall 8 news articles »
06/02/16 08:34 AMTarget Price and Stock Performance Rundown for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN - Target Price and Stock Performance Rundown for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)HNNDuring the latest trading session, Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) shares traded +0.00%. Monitoring the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent check, shares have been seen ...and more »
06/01/16 06:05 PMStock Sentiment Update:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - HNN - Stock Sentiment Update:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)HNNOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) has a current news sentiment score of 0. This data is given by Beta Research. On a scale between 1 and -1, a score of 1 would represent the news sentiment being positive. On the opposite side, a score of -1 would ...and more »
05/31/16 05:53 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Review of Stock Performance - HNN - Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Review of Stock PerformanceHNNDuring the most recent trading session, shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) have moved +0.804%. During the period, shares have moved to a high of $3.140 and fell to a low of $3.010. Broadening the view, the stock has range traded from ...and more »
05/31/16 05:53 PMStock Performance Check on : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - HNN - Stock Performance Check on : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)HNNTracking share activity in recent trading action, shares of Ohr Pharmaceutical, Inc. have been recorded 58.42% away from the 52 week low. Company shares have been recently seen -51.22% off of the 52 week high. The stock has been trading at 18.52% ...and more »
05/31/16 05:53 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Analyst Perspective on the Stock - Stock Tick Tock - Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Analyst Perspective on the StockStock Tick TockAnalysts on Wall Street have a future 12 month target price of $16 on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) shares. Analysts study the companies they cover in order to present the sell-side institutions with the information neeeded to make investment ...and more »
05/30/16 10:06 PMStock Performance Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - HNN - Stock Performance Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)HNNShares of Ohr Pharmaceutical, Inc.(NASDAQ:OHRP) have been recently seen at -52.59% away from the 52 week high and 53.96% separated from the 52 week low. If we move in a bit closer, the stock has been recently recorded at -22.25% away from the 50 ...and more »
05/30/16 10:06 PMStock Performance Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - HNN - Stock Performance Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)HNNShares of Ohr Pharmaceutical, Inc.(NASDAQ:OHRP) have been recently seen at -52.59% away from the 52 week high and 53.96% separated from the 52 week low. If we move in a bit closer, the stock has been recently recorded at -22.25% away from the 50 ...and more »
05/30/16 11:52 AMOhr Pharmaceutical Incorporated (NASDAQ:OHRP) Sellers Covered 1.64% of Their Shorts - HNN - Ohr Pharmaceutical Incorporated (NASDAQ:OHRP) Sellers Covered 1.64% of Their ShortsHNNThe short interest to Ohr Pharmaceutical Incorporated's float is 9.02%. The stock increased 0.97% or $0.03 on May 27, hitting $3.11. About 157,179 shares traded hands or 32.50% up from the average. OHR Pharmaceutical Inc (NASDAQ:OHRP) has risen ...and more »
05/27/16 11:22 AMStock Rating Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Stock Rating Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.67 on shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus ...and more »
05/27/16 11:22 AMJason Slakter, Chief Executive Officer of OHR Pharmaceutical Inc (NASDAQ:OHRP) Just Obtained Shares - Wall Street Hints and News - Analyst RatingsJason Slakter, Chief Executive Officer of OHR Pharmaceutical Inc (NASDAQ:OHRP) Just Obtained SharesWall Street Hints and NewsOhr Pharmaceutical Inc Chief Executive Officer Jason Slakter on the May 26, 2016 purchased a total of 3,682 shares of the stock exchange listed company with a total value of about $11,447 U.S. Dollars. This is calculated with average price per share of ...The CEO of OHR Pharmaceutical (NASDAQ: OHRP) is Buying SharesAnalyst Ratingsall 3 news articles »
05/27/16 11:22 AMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) News Sentiment Review - Wall Street Hints and News - Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) News Sentiment ReviewWall Street Hints and NewsOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) has a present news sentiment score of 0. This score is given by Beta Research using a scale from 1 to -1. A 1 score may indicate positive news sentiment while a score of -1 may indicate the opposite.
05/25/16 01:43 PMStock Sentiment Watch:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Stock Sentiment Watch:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) has a current news sentiment score of 0 provided by Beta Research. This calculated number lands on a scale between 1 and -1. A score of 1 would indicate the news sentiment as being positive. On the other side, ...and more »
05/21/16 01:28 PMAnalyst Rating Check on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Analyst Rating Check on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsCurrently, sell-side analysts have provided a consensus stock rating of 1.67 on shares of Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP). Analysts that cover the company will usually offer Buy, Sell, or Hold recommendations based on in-depth research.
05/21/16 01:28 PMRevenue Update on OHR Pharmaceutical Inc(NASDAQ:OHRP) - Trade Calls - Revenue Update on OHR Pharmaceutical Inc(NASDAQ:OHRP)Trade CallsOHR Pharmaceutical Inc(NASDAQ:OHRP) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on May 10, 2016. Earnings per share were $-0.17. Analysts had estimated an EPS of $-0.18. OHR Pharmaceutical ...Ohr Pharmaceutical Incorporated (NASDAQ:OHRP) Shorts Decreased by 3.13% After Short CoveringFranklin Independentall 4 news articles »
05/20/16 01:54 PMStock Mover in Focus : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Stock Mover in Focus : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsTrading activity of :Ohr Pharmaceutical, Inc.(NASDAQ:OHRP) shares gets the stock on today's active list. As of this writing, the change from the opening price is 1.67%. After a recent check, the stock price had reached $3.04. Company shares are ...and more »
05/20/16 01:54 PMCheck on Impact Score :Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Check on Impact Score :Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsTraders may be interested in tracking company sentiment and impact scores. Currently, Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) has been given an impact score of 100. The impact score is offered to provide current insight on how the stock might respond ...and more »
05/19/16 01:29 PMShare Performance and Target Price Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Share Performance and Target Price Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsLooking at stock activity from multiple angles may be of benefit when examining share performance. Investors have the ability to focus in on short or long term share performance. During the most recent trading session, Ohr Pharmaceuticals, Inc.and more »
05/19/16 01:29 PMEarnings View for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Wall Street Hints and News - Earnings View for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)Wall Street Hints and NewsCovering equity analysts are projecting Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) to report quarterly earnings per share of $N/A on a consensus basis. This number uses data provided by analysts polled by Zacks Research. The estimate may vary from ...and more »
05/19/16 12:04 PMOHR PHARMACEUTICAL INC Financials -
05/10/16 05:06 PMOHR PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition -
05/10/16 04:18 PMOHR reports 2Q loss -
About OHR Pharmaceutical

OHR Pharmaceutical logo

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OHRP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.73
  • 50 Day Moving Average: $2.96
  • 200 Day Moving Average: $3.56
  • P/E Ratio: N/A
  • P/E Growth: -0.03
  • Market Cap: $85.98M
  • Current Quarter EPS Consensus Estimate: $-1.07 EPS
Additional Links:
OHR Pharmaceutical (NASDAQ:OHRP) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha